Heart failure in immigrant groups: a cohort study of adults aged 45 years and over in Sweden

Per Wändell1, Axel C Carlsson1, Xinjun Li2

  • 1a Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society , Karolinska Institutet , Huddinge , Sweden.

Insights

Certain immigrant groups, particularly refugees, face a higher risk of developing congestive heart failure (CHF). Awareness and timely diagnosis are crucial for managing this condition.

Area of Science:

  • Cardiovascular Epidemiology
  • Public Health
  • Immigration Health

Background:

  • Previous studies indicate elevated risks for coronary heart disease and atrial fibrillation in immigrant populations.
  • The risk of congestive heart failure (CHF) among immigrants remains less understood.

Purpose of the Study:

  • To investigate the incidence of congestive heart failure (CHF) in various immigrant groups residing in Sweden.
  • To compare CHF risk between immigrant populations and the native-born Swedish population.

Main Methods:

  • A population-based cohort study in Sweden (1998-2012) included 3,274,119 adults aged ≥45 years.
  • Congestive heart failure (CHF) was identified through the National Patient Register.
  • Cox regression models, stratified by sex and adjusted for covariates, were used to assess incident CHF risk.

Main Results:

  • A total of 302,340 CHF events (9.2%) were recorded over a 14-year follow-up.
  • Higher CHF incidence was observed in men and women from Bosnia, Iraq, and Lebanon.
  • Lower incidence rates were noted in men and women from Iceland, Norway, and Western Europe.

Conclusions:

  • Specific immigrant groups, especially refugees, exhibit an increased incidence of congestive heart failure (CHF).
  • Increased awareness is vital for early diagnosis, effective treatment, and prevention of CHF complications.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319